Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RING-box protein 1 (RBX1) is a **conserved E3 ubiquitin ligase component** encoded by the RBX1 gene in humans[1][4]. It is an essential part of the Skp1–Cullin–F-box (SCF) complex (Cullin–RING ligase family), facilitating the transfer of ubiquitin from E2 enzymes to target proteins, thereby marking them for proteasome-mediated degradation[1][4]. RBX1 heterodimerizes with cullin proteins (CUL1, 2, 4A, 5, and 7), forming the catalytic core of E3 ligases involved in regulating protein turnover, cell cycle progression, and genomic stability[1][2][4]. RBX1 activity is critical for normal development, cell division, and cancer cell proliferation; its dysfunction or suppression leads to cell cycle arrest, DNA damage, apoptosis, and developmental lethality in model organisms[2][4]. It is also referred to as ROC1 or Regulator of Cullin 1. Targeting RBX1 or the SCF E3 ligase complex has therapeutic research interest in oncology, but broad inhibition may have significant safety challenges due to RBX1’s fundamental role in cellular homeostasis[4].
Inhibition of SCF (Skp1–Cullin–F-box) E3 ligase activity, Promotion of substrate degradation via the ubiquitin–proteasome pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RING-box protein 1 (RBX1).